NCI-Funded Colorectal Cancer Initiatives Aim to Increase Screening and Prevention Rates

March is Colorectal Cancer Awareness Month. According to the Centers for Disease Control and Prevention (CDC), an estimated 64 million adults aged 50 to 75 were screened for colorectal cancer in 2020, and 19.9% of adults in the same age range had never been screened. Read more

Geographic Accessibility and Disparities in Pediatric Cancer Care in the United States

In 2023, approximately 9910 US children will receive a cancer diagnosis. In the yearly pediatric mortality estimate, approximately 1040 patients aged 1 to 14 years will die of cancer progression/burden, making cancer the second-leading cause of death nationwide.Read More

Health Care Professionals Can Increase Access to Cancer Prevention Measures Among Patient Populations—Here’s How

February is National Cancer Prevention Month. With more than 40% of cancer diagnoses and mortality in the United States originating from preventable causes, there is a great need for more accessible prevention information and practices among American adults.Read More

Breaking Developments in DLBCL Research

According to a study published in the scientific journal Oncogene, diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma (NHL) diagnosed in the Western hemisphere, representing 30% to 40% of all NHL cases diagnosed every year in the United States. Read More

Adding Nab-Paclitaxel to Gemcitabine Plus Cisplatin Demonstrates No Significant OS Improvement in Advanced Biliary Tract Cancers

Rachna Shroff, MD, discusses the SWOG 1815 trial, which showed the addition of nab-paclitaxel to gemcitabine plus cisplatin demonstrated no significant improvement in OS for patients with advanced biliary tract cancers. Read More

Navitoclax Plus Ruxolitinib for Patients With Myelofibrosis: Review of Findings From the REFINE Trial | Sponsored by AbbVie

This article is sponsored by AbbVie. Combined navitoclax and ruxolitinib treatment has yielded encouraging response in patients with myelofibrosis (MF) enrolled on the REFINE trial. Read More

PSA Screening for Prostate Cancer is More Effective Than Previously Thought, Especially for Black Men

September is Prostate Cancer Awareness Month. Prostate cancer is the second most common cancer in men, and proactive screening can catch it early, giving men optimal opportunities for accessing treatment sooner. Read More

Breast Cancer Detection, Access to Care Dipped During the COVID-19 Pandemic

October is Breast Cancer Awareness Month. One in 8 women will be diagnosed with breast cancer in the United States and 1 in 3 patients will have metastatic disease.Read More

Everyday Diet Choices Impact Lung Cancer Risk Far Greater Than Americans Suspect

November is Lung Cancer Awareness Month. In this year alone, it is estimated that 23,740 new cases of lung cancer will be diagnosed and 130,180 lung cancer deaths will occur in the United States.1 Read More